In previous studies, DLGAP1‐AS1 was conformed to accelerate tumorigenesis and EMT process in hepatocellular carcinoma (Lin et al., 2020) and facilitate the cell invasion in gastric cancer (Deng et al., 2020). This evidence concerns the gene DLGAP1 and hepatocellular carcinoma.